Global Gene Therapy Market Research Report 2025(Status and Outlook)
Report Overview
Gene therapy is a medical intervention that involves modifying or manipulating a patient's genetic material to treat or prevent disease, typically by introducing, removing, or altering genetic code within cells to correct defective genes, enhance immune responses, or produce therapeutic proteins. This innovative approach holds transformative potential for addressing genetic disorders, cancers, and other chronic conditions by targeting the root cause at the molecular level. The market for gene therapy is rapidly evolving, driven by advancements in viral vector technologies (such as AAV and lentiviral vectors), CRISPR-based gene editing, and increased regulatory approvals for therapies targeting rare diseases. Key growth factors include rising investment in biotech R&D, strong pipeline activity with over 1,000 clinical trials underway globally, and a shift toward personalized medicine. However, challenges such as high treatment costs (often exceeding $1 million per patient), complex manufacturing processes, and long-term safety concerns remain significant barriers. The market is dominated by North America and Europe due to robust healthcare infrastructure and favorable reimbursement policies, while Asia-Pacific is emerging as a high-growth region with increasing government support and clinical trial activity. Major players include biopharmaceutical companies like Novartis, Spark Therapeutics, and bluebird bio, alongside specialized gene-editing firms such as CRISPR Therapeutics and Editas Medicine. With the global gene therapy market projected to exceed $20 billion by 2030, the sector is poised for expansion as innovations in delivery systems, scalability, and affordability unlock broader therapeutic applications.
The global Gene Therapy market size was estimated at USD 14816.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 27.88% during the forecast period.
This report provides a deep insight into the global Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy market in any manner.
Global Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Therapy
Non-Viral Gene Therapy
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapy Market
Overview of the regional outlook of the Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Gene therapy is a medical intervention that involves modifying or manipulating a patient's genetic material to treat or prevent disease, typically by introducing, removing, or altering genetic code within cells to correct defective genes, enhance immune responses, or produce therapeutic proteins. This innovative approach holds transformative potential for addressing genetic disorders, cancers, and other chronic conditions by targeting the root cause at the molecular level. The market for gene therapy is rapidly evolving, driven by advancements in viral vector technologies (such as AAV and lentiviral vectors), CRISPR-based gene editing, and increased regulatory approvals for therapies targeting rare diseases. Key growth factors include rising investment in biotech R&D, strong pipeline activity with over 1,000 clinical trials underway globally, and a shift toward personalized medicine. However, challenges such as high treatment costs (often exceeding $1 million per patient), complex manufacturing processes, and long-term safety concerns remain significant barriers. The market is dominated by North America and Europe due to robust healthcare infrastructure and favorable reimbursement policies, while Asia-Pacific is emerging as a high-growth region with increasing government support and clinical trial activity. Major players include biopharmaceutical companies like Novartis, Spark Therapeutics, and bluebird bio, alongside specialized gene-editing firms such as CRISPR Therapeutics and Editas Medicine. With the global gene therapy market projected to exceed $20 billion by 2030, the sector is poised for expansion as innovations in delivery systems, scalability, and affordability unlock broader therapeutic applications.
The global Gene Therapy market size was estimated at USD 14816.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 27.88% during the forecast period.
This report provides a deep insight into the global Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy market in any manner.
Global Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Therapy
Non-Viral Gene Therapy
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapy Market
Overview of the regional outlook of the Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene Therapy
1.2 Key Market Segments
1.2.1 Gene Therapy Segment by Type
1.2.2 Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy Product Life Cycle
3.3 Global Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy Market Competitive Situation and Trends
3.8.1 Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Gene Therapy Price by Type (2020-2025)
7 GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY MARKET SALES BY REGION
8.1 Global Gene Therapy Sales by Region
8.1.1 Global Gene Therapy Sales by Region
8.1.2 Global Gene Therapy Sales Market Share by Region
8.2 Global Gene Therapy Market Size by Region
8.2.1 Global Gene Therapy Market Size by Region
8.2.2 Global Gene Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Gene Therapy Sales by Country
8.3.2 North America Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy Sales by Country
8.4.2 Europe Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy Sales by Region
8.5.2 Asia Pacific Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy Sales by Country
8.6.2 South America Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy Sales by Region
8.7.2 Middle East and Africa Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy by Region(2020-2025)
9.2 Global Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy Production
9.4.1 North America Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy Production
9.5.1 Europe Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy Production (2020-2025)
9.6.1 Japan Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy Production (2020-2025)
9.7.1 China Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Gene Therapy Product Overview
10.1.3 Biogen Gene Therapy Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Gene Therapy Product Overview
10.2.3 Novartis Gene Therapy Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Gene Therapy Product Overview
10.3.3 Gilead Sciences Gene Therapy Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Basic Information
10.4.2 Sarepta Therapeutics Gene Therapy Product Overview
10.4.3 Sarepta Therapeutics Gene Therapy Product Market Performance
10.4.4 Sarepta Therapeutics Business Overview
10.4.5 Sarepta Therapeutics Recent Developments
10.5 Alnylam Pharmaceuticals
10.5.1 Alnylam Pharmaceuticals Basic Information
10.5.2 Alnylam Pharmaceuticals Gene Therapy Product Overview
10.5.3 Alnylam Pharmaceuticals Gene Therapy Product Market Performance
10.5.4 Alnylam Pharmaceuticals Business Overview
10.5.5 Alnylam Pharmaceuticals Recent Developments
10.6 Amgen
10.6.1 Amgen Basic Information
10.6.2 Amgen Gene Therapy Product Overview
10.6.3 Amgen Gene Therapy Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Basic Information
10.7.2 Spark Therapeutics Gene Therapy Product Overview
10.7.3 Spark Therapeutics Gene Therapy Product Market Performance
10.7.4 Spark Therapeutics Business Overview
10.7.5 Spark Therapeutics Recent Developments
10.8 Akcea Therapeutics
10.8.1 Akcea Therapeutics Basic Information
10.8.2 Akcea Therapeutics Gene Therapy Product Overview
10.8.3 Akcea Therapeutics Gene Therapy Product Market Performance
10.8.4 Akcea Therapeutics Business Overview
10.8.5 Akcea Therapeutics Recent Developments
10.9 bluebird bio
10.9.1 bluebird bio Basic Information
10.9.2 bluebird bio Gene Therapy Product Overview
10.9.3 bluebird bio Gene Therapy Product Market Performance
10.9.4 bluebird bio Business Overview
10.9.5 bluebird bio Recent Developments
10.10 Sunway Biotech
10.10.1 Sunway Biotech Basic Information
10.10.2 Sunway Biotech Gene Therapy Product Overview
10.10.3 Sunway Biotech Gene Therapy Product Market Performance
10.10.4 Sunway Biotech Business Overview
10.10.5 Sunway Biotech Recent Developments
10.11 SIBIONO
10.11.1 SIBIONO Basic Information
10.11.2 SIBIONO Gene Therapy Product Overview
10.11.3 SIBIONO Gene Therapy Product Market Performance
10.11.4 SIBIONO Business Overview
10.11.5 SIBIONO Recent Developments
10.12 AnGes
10.12.1 AnGes Basic Information
10.12.2 AnGes Gene Therapy Product Overview
10.12.3 AnGes Gene Therapy Product Market Performance
10.12.4 AnGes Business Overview
10.12.5 AnGes Recent Developments
10.13 Orchard Therapeutics
10.13.1 Orchard Therapeutics Basic Information
10.13.2 Orchard Therapeutics Gene Therapy Product Overview
10.13.3 Orchard Therapeutics Gene Therapy Product Market Performance
10.13.4 Orchard Therapeutics Business Overview
10.13.5 Orchard Therapeutics Recent Developments
10.14 Human Stem Cells Institute
10.14.1 Human Stem Cells Institute Basic Information
10.14.2 Human Stem Cells Institute Gene Therapy Product Overview
10.14.3 Human Stem Cells Institute Gene Therapy Product Market Performance
10.14.4 Human Stem Cells Institute Business Overview
10.14.5 Human Stem Cells Institute Recent Developments
11 GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Gene Therapy Market Size Forecast
11.2 Global Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy Market Size Forecast by Region
11.2.4 South America Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gene Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gene Therapy by Type (2026-2033)
12.1.2 Global Gene Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gene Therapy by Type (2026-2033)
12.2 Global Gene Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene Therapy
1.2 Key Market Segments
1.2.1 Gene Therapy Segment by Type
1.2.2 Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gene Therapy Product Life Cycle
3.3 Global Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Therapy Market Competitive Situation and Trends
3.8.1 Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Gene Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Gene Therapy Price by Type (2020-2025)
7 GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Therapy Sales Growth Rate by Application (2020-2025)
8 GENE THERAPY MARKET SALES BY REGION
8.1 Global Gene Therapy Sales by Region
8.1.1 Global Gene Therapy Sales by Region
8.1.2 Global Gene Therapy Sales Market Share by Region
8.2 Global Gene Therapy Market Size by Region
8.2.1 Global Gene Therapy Market Size by Region
8.2.2 Global Gene Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Gene Therapy Sales by Country
8.3.2 North America Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Therapy Sales by Country
8.4.2 Europe Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Therapy Sales by Region
8.5.2 Asia Pacific Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Therapy Sales by Country
8.6.2 South America Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Therapy Sales by Region
8.7.2 Middle East and Africa Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Gene Therapy by Region(2020-2025)
9.2 Global Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Therapy Production
9.4.1 North America Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Therapy Production
9.5.1 Europe Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Therapy Production (2020-2025)
9.6.1 Japan Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Therapy Production (2020-2025)
9.7.1 China Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Basic Information
10.1.2 Biogen Gene Therapy Product Overview
10.1.3 Biogen Gene Therapy Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Basic Information
10.2.2 Novartis Gene Therapy Product Overview
10.2.3 Novartis Gene Therapy Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Basic Information
10.3.2 Gilead Sciences Gene Therapy Product Overview
10.3.3 Gilead Sciences Gene Therapy Product Market Performance
10.3.4 Gilead Sciences Business Overview
10.3.5 Gilead Sciences SWOT Analysis
10.3.6 Gilead Sciences Recent Developments
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Basic Information
10.4.2 Sarepta Therapeutics Gene Therapy Product Overview
10.4.3 Sarepta Therapeutics Gene Therapy Product Market Performance
10.4.4 Sarepta Therapeutics Business Overview
10.4.5 Sarepta Therapeutics Recent Developments
10.5 Alnylam Pharmaceuticals
10.5.1 Alnylam Pharmaceuticals Basic Information
10.5.2 Alnylam Pharmaceuticals Gene Therapy Product Overview
10.5.3 Alnylam Pharmaceuticals Gene Therapy Product Market Performance
10.5.4 Alnylam Pharmaceuticals Business Overview
10.5.5 Alnylam Pharmaceuticals Recent Developments
10.6 Amgen
10.6.1 Amgen Basic Information
10.6.2 Amgen Gene Therapy Product Overview
10.6.3 Amgen Gene Therapy Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Basic Information
10.7.2 Spark Therapeutics Gene Therapy Product Overview
10.7.3 Spark Therapeutics Gene Therapy Product Market Performance
10.7.4 Spark Therapeutics Business Overview
10.7.5 Spark Therapeutics Recent Developments
10.8 Akcea Therapeutics
10.8.1 Akcea Therapeutics Basic Information
10.8.2 Akcea Therapeutics Gene Therapy Product Overview
10.8.3 Akcea Therapeutics Gene Therapy Product Market Performance
10.8.4 Akcea Therapeutics Business Overview
10.8.5 Akcea Therapeutics Recent Developments
10.9 bluebird bio
10.9.1 bluebird bio Basic Information
10.9.2 bluebird bio Gene Therapy Product Overview
10.9.3 bluebird bio Gene Therapy Product Market Performance
10.9.4 bluebird bio Business Overview
10.9.5 bluebird bio Recent Developments
10.10 Sunway Biotech
10.10.1 Sunway Biotech Basic Information
10.10.2 Sunway Biotech Gene Therapy Product Overview
10.10.3 Sunway Biotech Gene Therapy Product Market Performance
10.10.4 Sunway Biotech Business Overview
10.10.5 Sunway Biotech Recent Developments
10.11 SIBIONO
10.11.1 SIBIONO Basic Information
10.11.2 SIBIONO Gene Therapy Product Overview
10.11.3 SIBIONO Gene Therapy Product Market Performance
10.11.4 SIBIONO Business Overview
10.11.5 SIBIONO Recent Developments
10.12 AnGes
10.12.1 AnGes Basic Information
10.12.2 AnGes Gene Therapy Product Overview
10.12.3 AnGes Gene Therapy Product Market Performance
10.12.4 AnGes Business Overview
10.12.5 AnGes Recent Developments
10.13 Orchard Therapeutics
10.13.1 Orchard Therapeutics Basic Information
10.13.2 Orchard Therapeutics Gene Therapy Product Overview
10.13.3 Orchard Therapeutics Gene Therapy Product Market Performance
10.13.4 Orchard Therapeutics Business Overview
10.13.5 Orchard Therapeutics Recent Developments
10.14 Human Stem Cells Institute
10.14.1 Human Stem Cells Institute Basic Information
10.14.2 Human Stem Cells Institute Gene Therapy Product Overview
10.14.3 Human Stem Cells Institute Gene Therapy Product Market Performance
10.14.4 Human Stem Cells Institute Business Overview
10.14.5 Human Stem Cells Institute Recent Developments
11 GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Gene Therapy Market Size Forecast
11.2 Global Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy Market Size Forecast by Region
11.2.4 South America Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gene Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gene Therapy by Type (2026-2033)
12.1.2 Global Gene Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gene Therapy by Type (2026-2033)
12.2 Global Gene Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Gene Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 10. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gene Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gene Therapy Sales by Type (K Units)
Table 26. Global Gene Therapy Market Size by Type (M USD)
Table 27. Global Gene Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Gene Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Gene Therapy Market Size Share by Type (2020-2025)
Table 31. Global Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gene Therapy Sales (K Units) by Application
Table 33. Global Gene Therapy Market Size by Application
Table 34. Global Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Gene Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gene Therapy Market Share by Application (2020-2025)
Table 38. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Gene Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gene Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gene Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Biogen Basic Information
Table 62. Biogen Gene Therapy Product Overview
Table 63. Biogen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Biogen Business Overview
Table 65. Biogen SWOT Analysis
Table 66. Biogen Recent Developments
Table 67. Novartis Basic Information
Table 68. Novartis Gene Therapy Product Overview
Table 69. Novartis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Novartis Business Overview
Table 71. Novartis SWOT Analysis
Table 72. Novartis Recent Developments
Table 73. Gilead Sciences Basic Information
Table 74. Gilead Sciences Gene Therapy Product Overview
Table 75. Gilead Sciences Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Gilead Sciences Business Overview
Table 77. Gilead Sciences SWOT Analysis
Table 78. Gilead Sciences Recent Developments
Table 79. Sarepta Therapeutics Basic Information
Table 80. Sarepta Therapeutics Gene Therapy Product Overview
Table 81. Sarepta Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sarepta Therapeutics Business Overview
Table 83. Sarepta Therapeutics Recent Developments
Table 84. Alnylam Pharmaceuticals Basic Information
Table 85. Alnylam Pharmaceuticals Gene Therapy Product Overview
Table 86. Alnylam Pharmaceuticals Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Alnylam Pharmaceuticals Business Overview
Table 88. Alnylam Pharmaceuticals Recent Developments
Table 89. Amgen Basic Information
Table 90. Amgen Gene Therapy Product Overview
Table 91. Amgen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Amgen Business Overview
Table 93. Amgen Recent Developments
Table 94. Spark Therapeutics Basic Information
Table 95. Spark Therapeutics Gene Therapy Product Overview
Table 96. Spark Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Spark Therapeutics Business Overview
Table 98. Spark Therapeutics Recent Developments
Table 99. Akcea Therapeutics Basic Information
Table 100. Akcea Therapeutics Gene Therapy Product Overview
Table 101. Akcea Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Akcea Therapeutics Business Overview
Table 103. Akcea Therapeutics Recent Developments
Table 104. bluebird bio Basic Information
Table 105. bluebird bio Gene Therapy Product Overview
Table 106. bluebird bio Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. bluebird bio Business Overview
Table 108. bluebird bio Recent Developments
Table 109. Sunway Biotech Basic Information
Table 110. Sunway Biotech Gene Therapy Product Overview
Table 111. Sunway Biotech Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Sunway Biotech Business Overview
Table 113. Sunway Biotech Recent Developments
Table 114. SIBIONO Basic Information
Table 115. SIBIONO Gene Therapy Product Overview
Table 116. SIBIONO Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. SIBIONO Business Overview
Table 118. SIBIONO Recent Developments
Table 119. AnGes Basic Information
Table 120. AnGes Gene Therapy Product Overview
Table 121. AnGes Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. AnGes Business Overview
Table 123. AnGes Recent Developments
Table 124. Orchard Therapeutics Basic Information
Table 125. Orchard Therapeutics Gene Therapy Product Overview
Table 126. Orchard Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Orchard Therapeutics Business Overview
Table 128. Orchard Therapeutics Recent Developments
Table 129. Human Stem Cells Institute Basic Information
Table 130. Human Stem Cells Institute Gene Therapy Product Overview
Table 131. Human Stem Cells Institute Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Human Stem Cells Institute Business Overview
Table 133. Human Stem Cells Institute Recent Developments
Table 134. Global Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Gene Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Gene Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Gene Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Gene Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 10. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gene Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gene Therapy Sales by Type (K Units)
Table 26. Global Gene Therapy Market Size by Type (M USD)
Table 27. Global Gene Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Gene Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Gene Therapy Market Size Share by Type (2020-2025)
Table 31. Global Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Gene Therapy Sales (K Units) by Application
Table 33. Global Gene Therapy Market Size by Application
Table 34. Global Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Gene Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gene Therapy Market Share by Application (2020-2025)
Table 38. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Gene Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gene Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gene Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Biogen Basic Information
Table 62. Biogen Gene Therapy Product Overview
Table 63. Biogen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Biogen Business Overview
Table 65. Biogen SWOT Analysis
Table 66. Biogen Recent Developments
Table 67. Novartis Basic Information
Table 68. Novartis Gene Therapy Product Overview
Table 69. Novartis Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Novartis Business Overview
Table 71. Novartis SWOT Analysis
Table 72. Novartis Recent Developments
Table 73. Gilead Sciences Basic Information
Table 74. Gilead Sciences Gene Therapy Product Overview
Table 75. Gilead Sciences Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Gilead Sciences Business Overview
Table 77. Gilead Sciences SWOT Analysis
Table 78. Gilead Sciences Recent Developments
Table 79. Sarepta Therapeutics Basic Information
Table 80. Sarepta Therapeutics Gene Therapy Product Overview
Table 81. Sarepta Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sarepta Therapeutics Business Overview
Table 83. Sarepta Therapeutics Recent Developments
Table 84. Alnylam Pharmaceuticals Basic Information
Table 85. Alnylam Pharmaceuticals Gene Therapy Product Overview
Table 86. Alnylam Pharmaceuticals Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Alnylam Pharmaceuticals Business Overview
Table 88. Alnylam Pharmaceuticals Recent Developments
Table 89. Amgen Basic Information
Table 90. Amgen Gene Therapy Product Overview
Table 91. Amgen Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Amgen Business Overview
Table 93. Amgen Recent Developments
Table 94. Spark Therapeutics Basic Information
Table 95. Spark Therapeutics Gene Therapy Product Overview
Table 96. Spark Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Spark Therapeutics Business Overview
Table 98. Spark Therapeutics Recent Developments
Table 99. Akcea Therapeutics Basic Information
Table 100. Akcea Therapeutics Gene Therapy Product Overview
Table 101. Akcea Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Akcea Therapeutics Business Overview
Table 103. Akcea Therapeutics Recent Developments
Table 104. bluebird bio Basic Information
Table 105. bluebird bio Gene Therapy Product Overview
Table 106. bluebird bio Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. bluebird bio Business Overview
Table 108. bluebird bio Recent Developments
Table 109. Sunway Biotech Basic Information
Table 110. Sunway Biotech Gene Therapy Product Overview
Table 111. Sunway Biotech Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Sunway Biotech Business Overview
Table 113. Sunway Biotech Recent Developments
Table 114. SIBIONO Basic Information
Table 115. SIBIONO Gene Therapy Product Overview
Table 116. SIBIONO Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. SIBIONO Business Overview
Table 118. SIBIONO Recent Developments
Table 119. AnGes Basic Information
Table 120. AnGes Gene Therapy Product Overview
Table 121. AnGes Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. AnGes Business Overview
Table 123. AnGes Recent Developments
Table 124. Orchard Therapeutics Basic Information
Table 125. Orchard Therapeutics Gene Therapy Product Overview
Table 126. Orchard Therapeutics Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Orchard Therapeutics Business Overview
Table 128. Orchard Therapeutics Recent Developments
Table 129. Human Stem Cells Institute Basic Information
Table 130. Human Stem Cells Institute Gene Therapy Product Overview
Table 131. Human Stem Cells Institute Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Human Stem Cells Institute Business Overview
Table 133. Human Stem Cells Institute Recent Developments
Table 134. Global Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Gene Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Gene Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Gene Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Gene Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Gene Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy Product Life Cycle
Figure 13. Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Gene Therapy
Figure 19. Global Gene Therapy Market PEST Analysis
Figure 20. Global Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy by Type in 2024
Figure 29. Market Size Share of Gene Therapy by Type (2020-2025)
Figure 30. Market Size Share of Gene Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy Market Share by Application
Figure 33. Global Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy Sales Market Share by Application in 2024
Figure 35. Global Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy Market Share by Application in 2024
Figure 37. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy Market Size Market Share by Region in 2024
Figure 68. China Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gene Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gene Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Gene Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Gene Therapy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Gene Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gene Therapy Product Life Cycle
Figure 13. Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Gene Therapy
Figure 19. Global Gene Therapy Market PEST Analysis
Figure 20. Global Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Gene Therapy by Type in 2024
Figure 29. Market Size Share of Gene Therapy by Type (2020-2025)
Figure 30. Market Size Share of Gene Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gene Therapy Market Share by Application
Figure 33. Global Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Gene Therapy Sales Market Share by Application in 2024
Figure 35. Global Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Gene Therapy Market Share by Application in 2024
Figure 37. Global Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gene Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gene Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gene Therapy Market Size Market Share by Region in 2024
Figure 68. China Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Gene Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gene Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gene Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gene Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gene Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Gene Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Gene Therapy Market Share Forecast by Application (2026-2033)
